Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2,5-di-tert-butylbenzene-1,4-diol (BHQ): Selective SERCA ...

    2026-03-06

    2,5-di-tert-butylbenzene-1,4-diol (BHQ): Selective SERCA Inhibitor for Calcium Signaling Research

    Executive Summary: 2,5-di-tert-butylbenzene-1,4-diol (BHQ) is a potent, selective inhibitor of endoplasmic reticulum Ca2+-ATPase (SERCA) that disrupts intracellular calcium homeostasis by blocking SERCA-mediated transport (Li et al. 2025). BHQ induces mild ER stress, enhancing hematopoietic stem cell (HSC) mobilization via CaMKII-STAT3-CXCR4 pathway modulation (DOI). The compound modulates vascular smooth muscle contraction and can generate superoxide anions, which influence L-type Ca2+ channels. BHQ is water-insoluble but dissolves in ethanol and DMSO, supporting flexible experimental design (APExBIO). Its role in cardiovascular and regenerative medicine research is broadly documented and rapidly expanding (CalpaininhibitorII.com).

    Biological Rationale

    The endoplasmic reticulum (ER) Ca2+-ATPase (SERCA) is essential for maintaining intracellular calcium homeostasis. SERCA actively pumps Ca2+ from the cytosol into the sarcoplasmic/endoplasmic reticulum, enabling muscle relaxation and controlling calcium-dependent signaling cascades. Inhibition of SERCA leads to ER calcium store depletion, triggering compensatory calcium entry and ER stress responses (Li et al. 2025). These mechanisms underpin many physiological and pathological processes, including muscle contractility, stem cell mobilization, and cardiovascular regulation. Selective SERCA inhibitors like BHQ allow researchers to dissect these pathways with precision. Compared to other agents, BHQ offers improved selectivity and consistent performance across cell types (Ponesimodmolecule.com). This article extends the mechanistic focus of prior reviews by providing updated application benchmarks and evidence from recent in vivo studies.

    Mechanism of Action of 2,5-di-tert-butylbenzene-1,4-diol (BHQ)

    BHQ (SKU: B6648, supplied by APExBIO) is a synthetic, water-insoluble phenolic compound with molecular weight 222.33 g/mol. It selectively inhibits SERCA, blocking the ATP-dependent translocation of Ca2+ into the ER lumen. This leads to:

    • Depletion of ER Ca2+ stores and activation of store-operated calcium entry (SOCE) mechanisms.
    • Induction of mild ER stress, which can enhance HSC self-renewal and mobilization (Li et al. 2025).
    • Modulation of vascular smooth muscle contractility through effects on L-type Ca2+ channels and inward rectifier potassium currents (APExBIO).
    • Superoxide anion generation, further influencing ion channel function.

    BHQ is soluble in ethanol (≥45.8 mg/mL) and DMSO (≥8 mg/mL), but insoluble in water. Solutions should be prepared fresh and used promptly, as long-term stability is not guaranteed. For more detailed protocol guidance, see this workflow resource, which BHQ’s product page now supplements with updated in vivo data.

    Evidence & Benchmarks

    • BHQ rapidly induces ER Ca2+ depletion and triggers SOCE within minutes in cultured cells (Li et al. 2025, DOI).
    • In C57Bl/6 mouse models, BHQ administration significantly enhances HSC mobilization compared to controls, via the CaMKII-STAT3-CXCR4 pathway (Li et al. 2025, DOI).
    • BHQ modulates L-type Ca2+ currents and blocks inward rectifier potassium channels in vascular smooth muscle, with effects mediated in part by superoxide anions (APExBIO product data, product page).
    • Effective concentrations for SERCA inhibition in vitro typically range from 10–100 μM; higher concentrations may affect additional cellular targets (Ponesimodmolecule.com).
    • BHQ-induced ER stress enhances stem cell self-renewal and anti-apoptotic responses under mild stress conditions (Li et al. 2025, DOI).
    • BHQ has been benchmarked against other SERCA inhibitors and demonstrates comparable or superior selectivity and solubility in DMSO/ethanol systems (Calpaininhibitorii.com).

    Applications, Limits & Misconceptions

    BHQ is widely used in:

    • Calcium signaling research, including SOCE and ER stress studies.
    • Hematopoietic stem cell mobilization protocols, as demonstrated in recent in vivo mouse models (Li et al. 2025).
    • Vascular smooth muscle contractility assays and cardiovascular disease models.
    • Dissecting SERCA-mediated mechanisms in muscle relaxation and calcium channel regulation.

    For an evidence-based overview of these workflows, see this cell viability resource. Unlike prior reviews, this article provides new insight into BHQ’s concentration-dependent effects and recent HSC mobilization evidence.

    Common Pitfalls or Misconceptions

    • BHQ is not water-soluble: Attempting to dissolve BHQ in aqueous buffers leads to precipitation and assay variability (APExBIO).
    • Non-specific effects at high concentrations: Above 100 μM, BHQ can affect other ion channels and redox-sensitive pathways (Ponesimodmolecule.com).
    • BHQ is not a pan-ER stress inducer: Its effects are primarily mediated by SERCA inhibition, not by direct induction of unfolded protein response components (Li et al. 2025).
    • Not recommended for long-term solution storage: BHQ is prone to oxidation and should be freshly prepared before use (APExBIO).
    • Species and cell-type specificity: ER stress and Ca2+ mobilization outcomes may vary across species and cell lines.

    Workflow Integration & Parameters

    For optimal results, BHQ should be dissolved in DMSO or ethanol immediately prior to experimental use. Typical working concentrations range from 10 μM to 100 μM, depending on assay sensitivity. Store BHQ powder at room temperature in a desiccated environment. Avoid repeated freeze-thaw cycles of solutions. For hematopoietic stem cell mobilization, intraperitoneal injection in mice has been validated (Li et al. 2025). For vascular smooth muscle studies, BHQ can be added directly to tissue bath preparations. Detailed experimental design protocols are available on the APExBIO BHQ product page and in the linked ER calcium signaling review, which this article updates with new in vivo mobilization data.

    Conclusion & Outlook

    2,5-di-tert-butylbenzene-1,4-diol (BHQ) is a validated, selective SERCA inhibitor with broad utility in calcium signaling research, stem cell mobilization, and vascular physiology. Recent data underscore its capacity to enhance HSC mobilization via ER stress and CaMKII-STAT3-CXCR4 pathway modulation, with significant implications for regenerative medicine (Li et al. 2025). Its robust solubility in DMSO/ethanol and concentration-dependent effects support diverse experimental designs. For up-to-date protocols and ordering information, visit the 2,5-di-tert-butylbenzene-1,4-diol (BHQ) product page at APExBIO.